English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17524/19853 (88%)
Visitors : 6494728      Online Users : 636
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32308


    標題: Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion
    作者: Fang, Chia-Lang
    Uen, Yih-Huei
    Chen, Han-Kun
    Hseu, You-Cheng
    Lin, Chih-Chan
    Hung, Shih-Ting
    Sun, Ding-Ping
    Lin, Kai-Yuan
    貢獻者: Taipei Med Univ, Coll Med, Sch Med, Dept Pathol
    Taipei Med Univ, Wan Fang Hosp, Dept Pathol
    Asia Univ Hosp, Dept Surg
    Chi Mei Med Ctr, Dept Surg
    China Med Univ, Dept Cosmeceut
    Asia Univ, Dept Hlth & Nutr Biotechnol
    Chi Mei Med Ctr, Dept Med Res
    Chia Nan Univ Pharm & Sci, Dept Nutr
    Chia Nan Univ Pharm & Sci, Dept Biotechnol
    關鍵字: CDKL2
    gastric cancer
    immunohistochemistry
    prognosis
    日期: 2018-07
    上傳時間: 2019-11-15 15:49:00 (UTC+8)
    出版者: WILEY
    摘要: Cyclin-dependent kinase-like 2 (CDKL2), a new member of the cyclin-dependent kinase family, may be involved in gastric cancer (GC) progression. Thus, we conducted this study to explore the clinical effect of CDKL2 in GC. Immunohistochemistry was used to measure CDKL2 levels in gastric tissues. The association of a high CDKL2 level with clinical and pathological characteristics, and the correlation between the CDKL2 level and disease-free and overall survival were analyzed. Transfection was employed to overexpress CDKL2 in GC cells and to investigate the effect of CDKL2 overexpression on cell proliferation and invasion. Loss of CDKL2 was positively correlated with several clinical and pathological characteristics, and patients with a low CDKL2 level had significantly poorer disease-free and overall survival than those with a high level (P=.005 and .001, respectively). Univariate analysis using the Cox proportional hazards model indicated that a low CDKL2 level was a prognosticator for inferior disease-free survival (P=.007). Based on immmunoblotting data, AGS and HGC-27 GC cells were chosen for CDKL2 overexpression. Cellular studies revealed that CDKL2 overexpression impaired cell proliferation and invasion. Loss of CDKL2 may serve as a biomarker for predicting GC patient outcomes and a potential therapeutic target for GC treatment.
    link: http://dx.doi.org/10.1002/cam4.1577
    關聯: Indian Journal of Pharmaceutical Sciences, v.7, n.7, pp.2993-3002
    Appears in Collections:[保健營養系(所) ] 期刊論文
    [生物科技系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    10.1002-cam4.1577.pdf749KbAdobe PDF49View/Open
    index.html0KbHTML159View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback